Faghfuri, E. ., Nikfar, S. ., Niaz, K. ., Faramarzi, M. ., & Abdollahi, M. . (2018). Mitogen-activated protein kinase (MEK) inhibitors to treat melanoma alone or in combination with other kinase inhibitors. Expert Opinion on Drug Metabolism & Toxicology. https://doi.org/10.1080/17425255.2018.1432593 (Original work published 2018)